Press Release: Greenrose Acquisition Corp. Announces Extension of Time to Consummate Business Combinations
Press Release: Greenrose Acquisition Corp. Announces Extension of Time to Consummate Business Combinations
Greenrose Acquisition Corp. Announces Extension of Time to Consummate Business Combinations
格林羅斯收購公司宣佈延長完成業務合併的時間
AMITYVILLE, N.Y., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Greenrose Acquisition Corp. (OTC: GNRSU, GNRS, GNRSW) ("Greenrose" or the "Company"), a special purpose acquisition company targeting companies in the cannabis industry, provided notification to Continental Stock Transfer & Trust Company that it was exercising its option to extend the time available to consummate its previously announced business combinations to November 13, 2021 and deposited $569,250 into the Trust Account.
紐約阿米蒂維爾，2021年10月13日(Global Newswire)--Greenrose Acquisition Corp.(場外交易代碼：GNRSU，GNRS，GNRSW)(以下簡稱“Greenrose”或“公司”)是一家針對大麻行業公司的特殊目的收購公司，它通知大陸股票轉讓和信託公司，它正在行使選擇權，將完成之前宣佈的業務合併的可用時間延長到2021年11月13日，並將569,250美元存入信託賬户。
No Offer or Solicitation
沒有要約或邀約
This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall it constitute a solicitation of votes or proxies in connection with any meeting of the stockholders of Greenrose.
本通訊不構成出售任何證券的要約或徵求購買任何證券的要約，也不構成就Greenrose股東的任何會議徵求投票或委託書。
Advisors
顧問
Imperial Capital, LLC is acting as capital markets advisor to Greenrose. Gateway Group is serving as communications advisor to Greenrose. Mackenzie Partners and Broadridge Financial Solutions are acting as proxy advisors to Greenrose in connection with its proxy solicitation efforts.
帝國資本有限責任公司(Imperial Capital，LLC)擔任Greenrose的資本市場顧問。Gateway Group是Greenrose的公關顧問。麥肯齊合夥公司和Broadbridge金融解決方案公司將擔任Greenrose的代理顧問，與它的委託書徵集工作有關。
About Greenrose
關於格林羅斯
Greenrose Acquisition Corp. is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. Greenrose has entered into definitive agreements to acquire four cannabis companies, known collectively as "The Platform." The companies are Shango Holdings Inc. (Shango), Futureworks LLC (d/b/a The Health Center), Theraplant, LLC and True Harvest, LLC. The new Greenrose Platform will be a multistate operator that will look to further vertically and horizontally integrate in the markets that it is in and to enter new high growth and limited license markets.
Greenrose Acquisition Corp.是一家空白支票公司，成立的目的是與一個或多個企業或實體進行合併、換股、資產收購、股票購買、資本重組、重組或其他類似的業務合併。格林羅斯已經達成最終協議，將收購四家大麻公司，統稱為“The Platform”。這些公司是Shango Holdings Inc.(Shango)、Futureworks LLC(d/b/a the Health Center)、TheraPlant，LLC和True Heavest，LLC。新的Greenrose平台將是一家多州運營商，將尋求在其所處的市場中進一步縱向和橫向整合，並進入新的高增長和有限的許可證市場。
Forward-Looking Statements
前瞻性陳述
Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Greenrose's or its target companies' control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include: any inability to obtain Greenrose stockholder approval of the business combinations, any inability to complete the transaction contemplated by each of the respective merger or acquisition agreements because of failure of closing conditions or other reasons; any inability to recognize the anticipated benefits of the proposed business combinations, which may be affected by, among other things, the amount of cash available following any redemptions by Greenrose stockholders; liquidity of Greenrose's stock; costs related to the proposed business combinations; Greenrose's ability to manage growth; Greenrose's ability to identify and integrate other future acquisitions; rising costs adversely affecting Greenrose's profitability; competition in the legal cannabis industry; adverse changes to the legal environment for the cannabis industry; and general economic and market conditions impacting demand for Greenrose's products and services. See the risk factors disclosed in the preliminary proxy statement for the business combinations for additional risks associated with the business combinations. None of Greenrose, Shango Holdings Inc., Futureworks LLC (d/b/a The Health Center), Theraplant, LLC, or True Harvest, LLC undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Readers should not unduly rely on any projections or other forward-looking statements or data contained herein.
本新聞稿中的某些陳述屬於“1995年美國私人證券訴訟改革法”中“安全港”條款所指的“前瞻性陳述”。本新聞稿中使用的“估計”、“預計”、“預期”、“預期”、“預測”、“計劃”、“打算”、“相信”、“尋求”、“可能”、“將”、“應該”、“未來”、“建議”以及這些詞語或類似表述的變體(或此類詞語或表述的否定版本)旨在識別前瞻性陳述。這些前瞻性陳述不是對未來業績、條件或結果的保證，涉及許多已知和未知的風險、不確定性、假設和其他重要因素，其中許多不在Greenrose公司或其目標公司的控制範圍之內，這些因素可能導致實際結果或結果與前瞻性陳述中討論的大不相同。除其他外，可能影響實際結果或結果的重要因素包括：任何無法獲得Greenrose股東對業務合併的批准、任何由於未能履行成交條件或其他原因而無法完成各自合併或收購協議所設想的交易、任何無法確認擬議業務合併的預期收益，這些都可能受到其他因素的影響。, Greenrose股東贖回後的可用現金數額；Greenrose股票的流動性；與擬議的業務合併相關的成本；Greenrose管理增長的能力；Greenrose識別和整合其他未來收購的能力；成本上升對Greenrose的盈利能力產生不利影響；合法大麻行業的競爭；大麻行業法律環境的不利變化；以及影響Greenrose產品和服務需求的總體經濟和市場條件。有關業務合併的額外風險，請參閲初步委託書中披露的有關業務合併的風險因素。除非法律另有要求，否則Greenrose、Shango Holdings Inc.、Futureworks LLC(d/b/a the Health Center)、TheraPlant，LLC或True Heavest，LLC均不承擔更新或修改任何前瞻性陳述的義務，無論是由於新信息、未來事件還是其他原因。讀者不應過度依賴本文中包含的任何預測或其他前瞻性陳述或數據。
Additional Information About the Proposed Business Combination and Where to Find It
有關提議的業務合併的更多信息以及在哪裏可以找到它
For additional information about the proposed business combinations, see Greenrose's Definitive Proxy Statement on Schedule 14A filed with the SEC on October 5, 2021 available at www.sec.gov.
有關擬議的業務合併的更多信息，請參見格林羅斯於2021年10月5日提交給證券交易委員會的關於附表14A的最終委託書，可在www.sec.gov上查閲。
The proposed transactions will be submitted to shareholders of Greenrose for their approval. In connection with the proposed business combinations, Greenrose will file with the SEC a preliminary and definitive proxy statements in connection with a special meeting of the stockholders of Greenrose to consider and vote on the business combination and related matters. Greenrose will mail the definitive proxy statement and other relevant documents to its stockholders in connection with the meeting. Investors and security holders of Greenrose are advised to read, when available, the draft of the preliminary proxy statement, and amendments thereto, and the definitive proxy statement, which will contain important information about the proposed business combinations and the parties to it. The definitive proxy statement will be mailed to stockholders of Greenrose as of a record date to be established for voting on the proposed business combinations. Stockholders will also be able to obtain copies of the proxy statement, without charge, once available, at the SEC's website at www.sec.gov or by directing a request to: Greenrose Acquisition Corp., 111 Broadway, Amityville, NY 11701, Attention: Chief Executive Officer.
擬議的交易將提交給Greenrose的股東批准。關於擬議的業務合併，Greenrose將向證券交易委員會提交一份與Greenrose股東特別會議有關的初步和最終委託書，以審議業務合併和相關事項並進行投票。Greenrose將向其股東郵寄與此次會議有關的最終委託書和其他相關文件。建議Greenrose的投資者和證券持有人閲讀初步委託書草案及其修正案，以及最終委託書，其中將包含有關擬議的業務合併及其各方的重要信息。最終委託書將在創紀錄的日期郵寄給Greenrose的股東，以確定對擬議的業務合併進行投票的日期。股東還可以在證券交易委員會網站www.sec.gov上免費獲得委託書的副本，或直接向Greenrose Acquisition Corp.索取，地址為：Greenrose Acquisition Corp.，1111Broadway，Amityville，NY 11701，注意：首席執行官。
Participants in the Solicitation
參與徵集活動的人士
Greenrose, True Harvest and Theraplant, and their respective directors, executive officers and other members of their management and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of Greenrose stockholders in connection with the proposed business combinations. Investors and security holders may obtain more detailed information regarding the names, affiliations and interests of Greenrose's directors in the final prospectus for Greenrose's initial public offering dated as of February 11, 2020, and that was filed with the SEC on February 11, 2020, as well as in its annual report on Form 10-K filed with the SEC on March 11, 2021. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests will be contained in the preliminary and definitive proxy statements related to the proposed business combinations when it becomes available, and which can be obtained free of charge from the sources indicated above.
根據證券交易委員會的規定，Greenrose、True Heavest和TheraPlant及其各自的董事、高管以及管理層和員工的其他成員可能被視為與擬議的業務合併相關的Greenrose股東的委託書徵集活動的參與者。投資者和證券持有人可以在截至2020年2月11日提交給證券交易委員會的Greenrose首次公開募股的最終招股説明書以及2021年3月11日提交給證券交易委員會的Form 10-K年度報告中獲得有關Greenrose董事姓名、從屬關係和利益的更詳細信息。有關委託書徵集參與者的更多信息以及對他們直接和間接利益的描述將包含在與擬議的業務合併有關的初步和最終委託書陳述中，這些陳述可以從上述來源免費獲得。
Investor Relations Contact:
投資者關係聯繫人：
Gateway Investor Relations
網關投資者關係
Cody Slach or Jackie Keshner
Cody Slach或Jackie Keshner
(949) 574-3860
(949) 574-3860
GNRS@gatewayir.com
郵箱：gnrs@gatewayir.com
Greenrose Contact:
格林羅斯聯繫方式：
Daniel Harley
丹尼爾·哈雷
Executive Vice President, Business Development
負責業務發展的執行副總裁
(516) 307-0383
(516) 307-0383
ir@greenrosecorp.com
郵箱：ir@greenrosecorp.com
譯文內容由第三人軟體翻譯。